Putnam Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,984
| Closed | -$290K | – | 1216 |
|
|
2022
Q3 | $290K | Buy |
10,984
+2,051
| +23% | +$54.2K | ﹤0.01% | 1085 |
|
|
2022
Q2 | $397K | Sell |
8,933
-108
| -1% | -$4.8K | ﹤0.01% | 998 |
|
|
2022
Q1 | $448K | Sell |
9,041
-651
| -7% | -$32.3K | ﹤0.01% | 1040 |
|
|
2021
Q4 | $493K | Buy |
+9,692
| New | +$493K | ﹤0.01% | 1030 |
|
|
2017
Q2 | – | Sell |
-78,412
| Closed | -$6.5M | – | 1322 |
|
|
2017
Q1 | $6.5M | Sell |
78,412
-27,844
| -26% | -$2.31M | 0.02% | 500 |
|
|
2016
Q4 | $8.43M | Buy |
106,256
+14,981
| +16% | +$1.19M | 0.02% | 417 |
|
|
2016
Q3 | $6.39M | Sell |
91,275
-24,745
| -21% | -$1.73M | 0.02% | 492 |
|
|
2016
Q2 | $4.5M | Buy |
116,020
+22,912
| +25% | +$889K | 0.01% | 663 |
|
|
2016
Q1 | $3.77M | Buy |
93,108
+8,658
| +10% | +$351K | 0.01% | 757 |
|
|
2015
Q4 | $7.49M | Buy |
84,450
+27,100
| +47% | +$2.4M | 0.02% | 540 |
|
|
2015
Q3 | $4.25M | Buy |
57,350
+18,150
| +46% | +$1.34M | 0.01% | 727 |
|
|
2015
Q2 | $3.17M | Buy |
+39,200
| New | +$3.17M | 0.01% | 900 |
|